Counterpoint Quantitative Equity ETF (NYSE:CPAI – Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 15th, there was short interest totaling 36,564 shares, a drop of 42.0% from the September 30th total of 63,048 shares. Based on an average trading volume of 80,938 shares, the short-interest ratio is presently 0.5 days. Currently, 0.4% of the company’s shares are short sold.
Institutional Investors Weigh In On Counterpoint Quantitative Equity ETF
Institutional investors and hedge funds have recently made changes to their positions in the stock. NewEdge Advisors LLC raised its holdings in shares of Counterpoint Quantitative Equity ETF by 230.6% during the second quarter. NewEdge Advisors LLC now owns 111,269 shares of the company’s stock valued at $5,782,000 after acquiring an additional 77,610 shares during the last quarter. Counterpoint Mutual Funds LLC grew its stake in shares of Counterpoint Quantitative Equity ETF by 5.3% in the 1st quarter. Counterpoint Mutual Funds LLC now owns 1,549,616 shares of the company’s stock valued at $64,758,000 after buying an additional 78,500 shares during the period. Royal Bank of Canada grew its stake in shares of Counterpoint Quantitative Equity ETF by 122.6% in the 1st quarter. Royal Bank of Canada now owns 44,196 shares of the company’s stock valued at $1,847,000 after buying an additional 24,338 shares during the period. Independent Financial Group LLC acquired a new stake in shares of Counterpoint Quantitative Equity ETF during the 1st quarter worth approximately $3,154,000. Finally, Hilltop Holdings Inc. acquired a new stake in shares of Counterpoint Quantitative Equity ETF during the 1st quarter worth approximately $459,000.
Counterpoint Quantitative Equity ETF Stock Down 2.0%
CPAI traded down $1.04 during trading hours on Monday, reaching $51.56. 56,187 shares of the company’s stock traded hands, compared to its average volume of 59,657. Counterpoint Quantitative Equity ETF has a 52-week low of $37.29 and a 52-week high of $53.96. The firm has a 50-day moving average price of $52.43 and a 200 day moving average price of $48.37. The firm has a market capitalization of $526.94 million, a PE ratio of -61,822.54 and a beta of 1.17.
About Counterpoint Quantitative Equity ETF
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
Featured Stories
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
